Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0) [Phase 2]
Phase 2 trial exploring vinorelbine metronomic chemotherapy with hypofractionated radiotherapy followed by PD-1/PD-L1 sequential GM-CSF and …
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update for T3011 administered intratumorally in advanced solid tumors, including phase 1 and phase 2 cohorts.
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients" [Phase 2, Phase 3]
A clinical trial evaluating the therapeutic effect of atorvastatin in HER2-negative breast cancer across Phase 2 and Phase 3 stages; current…
-
CLINICAL_TRIALS trial_result · 2022-11-01Clinical Trial Update: Evaluating Tocilizumab for Sever COVID-19 Infection in Breast Cancer vs. Non Cancer Pateints [Phase 2]
Phase 2 trial evaluating tocilizumab for severe COVID-19 infection in breast cancer patients compared to non-cancer patients; study complete…
-
CLINICAL_TRIALS trial_result · 2022-11-01Clinical Trial Update: Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells [Phase 2]
Phase 2 trial investigating whether trastuzumab affects disease-free survival in early-stage HER2-negative breast cancer patients with ERBB2…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-10-31Clinical Trial Update: The Anti-tumor Effect of Metformin And Atorvastatin in Breast Cancer [Phase 4]
Phase 4 trial evaluating anti-tumor effects of metformin and atorvastatin in breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-10-27Clinical Trial Update: Epirubicin Versus Docetaxel Plus Cyclophosphamide in Lymph Node Negative, ER-positive, Her2-negative Breast Cancer [Phase 4]
Phase 4 trial comparing Epirubicin to Docetaxel plus Cyclophosphamide in lymph node negative, ER-positive, HER2-negative breast cancer has c…
-
CLINICAL_TRIALS trial_result · 2022-10-27Clinical Trial Update: Neoadjuvant Nab-paclitaxel in Triple-negative or HER2-positive Breast Cancer [Phase 2]
Phase 2 trial update studying neoadjuvant nab-paclitaxel in triple-negative or HER2-positive breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protocol TX05-03 [Phase 3]
A Phase 3 extension study evaluating adjuvant treatment after neoadjuvant therapy and surgery in HER2-positive early-stage breast cancer has…
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients [Phase 2, Phase 3]
A combined Phase 2/Phase 3 trial investigating silymarin to mitigate chemotherapy toxicity and improve cognition in breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: Neoadjuvant MEDI4736 Concomitant With Weekly Nab-paclitaxel and Dose-dense AC for Stage I-III Triple Negative Breast Cancer [Phase 1, Phase 2]
A completed Phase 1/2 study evaluated neoadjuvant MEDI4736 (durvalumab) with weekly nab-paclitaxel and dose-dense AC in Stage I-III triple-n…
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: Accelerated Hypofractionated 1 Week Radiotherapy in Breast Cancer Patients [Phase 3]
Phase 3 trial update on Accelerated Hypofractionated 1 Week Radiotherapy in breast cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: A Study of Pyrotinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer [Phase 3]
A Phase 3 clinical trial update evaluating pyrotinib plus capecitabine for HER2-positive metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: A Phase II Window of Opportunity Trial of PRMT5 Inhibitor, GSK3326595, in Early Stage Breast Cancer [Phase 2]
Phase II window-of-opportunity trial evaluating PRMT5 inhibitor GSK3326595 in early-stage breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-10-24Clinical Trial Update: Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients [Phase 2]
Phase 2 clinical trial update on using crofelemer to prevent diarrhea in HER2-positive breast cancer patients has completed with posted resu…
-
CLINICAL_TRIALS trial_result · 2022-10-21Clinical Trial Update: Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients [Phase 3]
Phase 3 clinical trial evaluating lithium for chemotherapy-induced neutropenia in breast cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2022-10-21Clinical Trial Update: Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer [Phase 2]
A Phase 2 trial comparing letrozole alone versus letrozole with Avastin in post-menopausal women with breast cancer has completed and posted…
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: Pre-Surgical Study: Effect of Metformin on Breast Cancer Proliferation [Phase 2]
A Phase 2 pre-surgical trial assessing the effect of metformin on breast cancer proliferation has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) [NA]
Clinical trial update for S1415CD (TrACER) reporting completed status with results posted; study involves CSF prescribing effectiveness and …
-
CLINICAL_TRIALS trial_result · 2022-10-19Clinical Trial Update: 4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast Cancer [Phase 1]
Phase 1 trial evaluating PF-05082566 (4-1BB agonist) with trastuzumab emtansine or trastuzumab in advanced HER2-positive breast cancer; stud…
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer [Phase 2]
Phase 2 neoadjuvant endocrine therapy trial in hormone receptor-positive, HER2-negative, node-negative breast cancer completed. Results post…
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer [Phase 3]
Phase III trial evaluating metformin versus placebo in early-stage breast cancer completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2022-10-13Clinical Trial Update: Pilot Study of Paclitaxel Plus Pembrolizumab in Metastatic HER2-Negative Breast Cancer [Phase 2]
Phase 2 pilot study evaluating the combination of paclitaxel and pembrolizumab in metastatic HER2-negative breast cancer has completed with …
-
CLINICAL_TRIALS trial_result · 2022-10-13Clinical Trial Update: Exploring Whether Disease-free Intervals Can Guide Endocrine Combined Targeted Therapy for ER+/HER2+ Advanced Breast Cancer (T-sunflower) [Phase 2]
A Phase 2 trial investigating whether disease-free intervals can guide endocrine combined targeted therapy for ER+/HER2+ metastatic breast c…
-
CLINICAL_TRIALS trial_result · 2022-10-13Clinical Trial Update: Nab-paclitaxel Dose Schedual for HER-2 Negative Advanced Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating nab-paclitaxel dosing schedule for HER-2 negative advanced breast cancer.